Shining a Light on Drug Development: Revolutionizing Radiolabeling

Article   Nov 09, 2017 | by Laura Elizabeth Mason, Science Editor, Technology Networks

 
Shining a Light on Drug Development: Revolutionizing Radiolabeling

A blue LED shines on a vial containing heavy water, a pharmaceutical compound, and a light-activated catalyst. The new photocatalytic approach from Princeton's David MacMillan turns a multi-month process into a one-day step, speeding the arrival of new drugs to the marketplace. Credit: David MacMillan/Princeton University

Laura Mason

Scientific Editor

 
 
 

RELATED ARTICLES

New Crystal Structure of (Ph)PINK1 Aids Understanding of Early Onset Parkinson’s

Article

Scientists have determined the crystal structure of PhPINK1 bound to it's substrate ubiquitin. Mutations of PINK1 are associated with early onset Parkinson's disease and it is expected that this information will help the design of Parkinson's therapeutics.

READ MORE

Pumpkins Hold the Key to Natural Disinfectants

Article

Specific bacterial communities found on Styrian oilseed pumpkins were found to produce highly effective volatiles that inhibited the growth of both human and plant pathogens. The discovery has been applied to decontamination of hatching eggs which is currently performed using toxic formaldehyde.

READ MORE

Phenotypic Screening in Drug Discovery

Article

There is an ever-growing curiosity in the potential benefit of combining phenotypic and genomic data, in the quest to advance small-molecule drug discovery. Understanding the advantages and challenges of phenotypic screening will help enhance its value as a tool for identifying drug candidates.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE